Hexagon Capital Partners LLC Innoviva, Inc. Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 26 shares of INVA stock, worth $524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$524% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INVA
# of Institutions
221Shares Held
79.5MCall Options Held
20KPut Options Held
5.4K-
Black Rock Inc. New York, NY9.63MShares$194 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$147 Million20.14% of portfolio
-
Franklin Resources Inc San Mateo, CA6.62MShares$134 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$127 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$125 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.41B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...